Home | Previous Conference Alerts | Healthcare-medical-events | 9th Annual Clinical Trials Summit 2018

9th Annual Clinical Trials Summit 2018

9th Annual Clinical Trials Summit 2018, which is going to be held in Mumbai on 22nd May 2018.
  • Event Date:

    22 May 2018
Virtue Insight welcomes you to attend the 9th Annual Clinical Trials Summit 2018, which is going to be held in Mumbai on 22nd May 2018. We cordially invite all the participants who are interested in sharing their knowledge and research in the arena of Clinical Trials. 9th Annual Clinical Trials Summit 2018 anticipates participants around the globe with thought provoking Keynote lectures, Oral Presentations and Poster Presentations. This is an excellent opportunity for the delegates from Universities and Institutes to interact with the world class Scientists. The main theme of the conference is to positively learn and educate about clinical trials is essential, if only to counter more negative perceptions.


• OMPRAKASH S. SADHWANI, Joint Commissioner (Nashik Division), Food and Drugs Administration (M.S.)
• K. BANGARURAJAN, Joint Drugs Controller (INDIA), CDSCO (HQ)
• MAYUR PARMAR, Deputy Collector, Government of Gujarat
• NILIMA A. KSHIRSAGAR, National Chair Clinical Pharmacology, ICMR Govt. of India
• MUZAFFAR AHMAD, Member Strategic Advisory Board on Health Millenium Alliance (Govt of India) and Member Council of India
• DEVEN V PARMAR, Vice President & Head Clinical R&D, Cadila Healthcare
• ARUN BHATT, Consultant - Clinical Research & Development
• SANDESH SAWANT, Director and Head Clinical Trials, Cipla
• CHIRAG TRIVEDI, Director & Head of Clinical Study Unit, Sanofi-aventis
• DILIP PAWAR, Director and Head - Clinical Development and Medical - Emerging Market including APAC, Merck Sharp & Dohme
• SHIRAZ KANDAWALLA, Associate Director - Regulatory Affairs, Abbott
• BINDU AJIT, Program Director, Biocon Academy
• AMMAR RAZA, Country Medical Director & Chief Medical Office, Allergan
• KEDAR SUVARNAPATHAKI, Head - Regulatory Affairs & IP, Boehringer Ingelheim
• MILIND ANTANI, Partner In-Charge - Pharma LifeSciences, Nishith Desai Associates
• SIDDHARTH DESHPANDE, Assistant Professor Department of Clinical Pharmacology, KEM Hospital
• AGAM SHAH, Head Clinical Operations, Wockhardt
• JYOTSNA PATWARDHAN, Head Development QA, Novartis
• CHIRAG TELI, Head of Medical Services, Alkem Laboratories
• AMEY MANE, General Manager - Medical Affairs, Janssen India (Pharmaceutical companies of Johnson & Johnson)
• SUJAY SURESH KULKARNI, Senior Manager - Medical and Regulatory Affairs, GSK
• RANJIT BARSHIKAR, QbD / CGMP Consulting, Member Editorial Board Journal of Generic Medicines, England
• PRANJAL BORDOLOI, AVP - Medical Affairs and Pharmacovigilance, Veeda Clinical Research
• PRASHANT BODHE, Director, CliniSearch


• Current challenges and regulations for clinical trials in India
• Having a positive impact on overall market to globalize trials and growth in new product development in emerging countries
• Formulating a risk-based inspection plan for advanced clinical trials
• New tools and technologies for data capture for clinical trials
• Developing effective partnerships and vendor relationships
• Necessary strategies to implement the maximize value of the collaboration.
• Patient and clinical site centricity: Optimising the end users, patients and the clinical sites
• Encouraging data analytics for next-generation clinical trials
• EHR (Electronic Health Records) for clinical research facility
• Recent guidelines issued by FDA on the use of EHR data
• Major roles of clinical pharmacology in drug discovery and development
• New clinical trials rules and its impact
• Current requirements of Indian Clinical Trial Application (CTA) and how this will change with the new clinical trial regulation
• Regulatory considerations in India and south-east Asia
• Be part of a major networking opportunity


CEOs, CTOs, CIOs, Presidents, Vice Presidents, Directors Heads & Managers of:
Clinical Research & Development, Clinical Research Services, Clinical Operations, Clinical Data Management, Clinical IT, Clinical Trials, Medical Affairs, Regulatory Affairs, Compliance, Quality control / Assurance/GCP, Clinical Study Design, Safety Surveillance, Subject Recruitment, E-Clinical Systems


• Standard Price – 1 or 2 Delegates - (INR 7,000 + GST (18%) per delegate)
• Group Discounts – 3 or 4 Delegates - (INR 6,500 + GST (18%) per delegate)
• Group Discounts – 5 and above Delegates - (INR 6,000 + GST (18%) per delegate)
• Spot Registration on the day of the Conference – 1 Day Conference - (INR 8,000 + GST (18%) per delegate)
• Conference Sponsor & Exhibition Stall( Booth) or a paid Speaker Slot are also available.

For More Information -
JSB Conference Events team
Mobile: +91 9987295242


  • Avani Das

    speaker 1

    Position :

  • speaker 1

    Position :

  • speaker 1

    Position :


The JSB Daily Newsletter

Join more than 150,000 leading professionals who rely on us